Beaird Harris Wealth Management, LLC Q2 2022 Filing

Filed August 12, 2022

Portfolio Value

$362.9B

Holdings

429

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (429 positions)

#StockSharesValue% PortfolioType
401
BDTXBLACK DIAMOND THERAPEUTICS I
36$00.00%
402
10X CAP VENTURE ACQSTN CORP
1,084$00.00%
403
TDYTELEDYNE TECHNOLOGIES INC
1$00.00%
404
BCELATRECA INC
77$00.00%
405
SHELSHELL PLC
9$00.00%
406
FATHOM DIGITAL MFG CORP
1,000$00.00%
407
DOCUDOCUSIGN INC
8$00.00%
408
HARPOON THERAPEUTICS INC
149$00.00%
409
SPROSPERO THERAPEUTICS INC
282$00.00%
410
EP3ORASURE TECHNOLOGIES INC
83$00.00%
411
GREENLANE HLDGS INC
2,457$00.00%
412
FIXXEURHOMOLOGY MEDICINES INC
163$00.00%
413
GBYSANGAMO THERAPEUTICS INC
87$00.00%
414
AURAURORA INNOVATION INC
250$00.00%
415
YEXTYEXT INC
61$00.00%
416
CABACABALETTA BIO INC
79$00.00%
417
RBOTWVICARIOUS SURGICAL INC
250$00.00%
418
SVF INVESTMENT CORP
82$00.00%
419
LOGICBIO THERAPEUTICS INC
114$00.00%
420
EBSEMERGENT BIOSOLUTIONS INC
12$00.00%
421
RYTMRHYTHM PHARMACEUTICALS INC
49$00.00%
422
CCLCARNIVAL CORP
50$00.00%
423
APTALPHA PRO TECH LTD
75$00.00%
424
WBDWARNER BROS DISCOVERY INC
1$00.00%
425
FOUNDER SPAC
1,000$00.00%
426
TNXPTONIX PHARMACEUTICALS HLDG C
79$00.00%
427
HOOKGBPHOOKIPA PHARMA INC
92$00.00%
428
NYMTEURNEW YORK MTG TR INC
66$00.00%
429
QUANERGY SYSTEMS INC
1,190$00.00%
PreviousPage 5 of 5